关于肝细胞癌中铁亡的全球研究现状和前沿研究:全面的文献计量和可视化分析
Jiayu Zhu1, Shengping Luo2, Fei Yu1
1The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.
Frontiers in immunology
|May 19, 2025
概括
这种图书统计分析揭示了肝细胞癌中铁亡的关键研究趋势. 新兴的研究重点是治疗策略和目标,表明未来的发展方向.
科学领域:
- 在瘤学瘤学.
- 生物医学研究生物医学研究
- 分子生物学分子生物学
背景情况:
- 铁灭症越来越多地因其在肝细胞癌中的作用而得到认可.
- 了解铁亡机理对于开发新型癌症疗法至关重要.
研究的目的:
- 分析过去十年来肝细胞癌的铁亡研究热点和趋势.
- 为这个领域的未来研究方向提供见解.
主要方法:
- 从2012年到2024年对出版物的图书统计分析.
- 使用VOSviewer和CiteSpace进行数据可视化和分析.
- 包括来自32个国家的645篇英语文章.
主要成果:
- 出版物显著增加,在过去三年中增加了80.3%.
- 中国和美国在研究成果方面处于领先地位.
- 关键的研究领域包括治疗标的铁灭机制和新型疗法,如光动力学疗法和纳米材料.
结论:
- 这是关于肝细胞癌中铁亡的第一个全面的文献计量研究.
- 结果为未来该领域的研究和开发提供了可靠的参考.
相关概念视频
Necrosis
3.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


